Fetal hemoglobin and F-cell variance in mobilized CD34+ cell-transplanted rhesus monkeys

Exp Hematol. 2019 Jul:75:21-25.e1. doi: 10.1016/j.exphem.2019.05.005. Epub 2019 Jun 5.

Abstract

Elevated fetal hemoglobin (HbF) is associated with reduced severity of sickle cell disease. Therefore, γ-globin protein levels and F-cell (HbF-positive red blood cell) percentages are used for estimation of clinical benefit. Here, we monitored transplantation-related changes in HbF and F-cell percentages for rhesus macaques (Macaca mulatta) following total body irradiation or busulfan conditioning prior to CD34+ cell transplantation. HbF protein expression peaked in the first 4-9 weeks posttransplant (0.99%-2.53%), and F-cells increased in the first 6-17 weeks posttransplant (8.7%-45.3%). HbF and F-cell ratios gradually decreased and stabilized to levels similar to those of control animals (1.96 ± 1.97% for F cells and 0.49 ± 0.19% γ-globin expression) 4-7 months post-transplant. These findings confirm and expand on previous reports of transient induction in HbF and F-cell percentages in rhesus macaques following CD34+ cell transplantation, an observation that must be taken into consideration when evaluating therapeutic strategies that aim to specifically elevate HbF expression, which are currently in clinical development.

Publication types

  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allografts
  • Anemia, Sickle Cell / blood*
  • Anemia, Sickle Cell / therapy*
  • Animals
  • Antigens, CD34 / metabolism
  • Busulfan / pharmacology
  • Erythrocytes, Abnormal / metabolism*
  • Erythrocytes, Abnormal / pathology
  • Fetal Hemoglobin / metabolism*
  • Hematopoietic Stem Cell Mobilization*
  • Hematopoietic Stem Cell Transplantation*
  • Macaca mulatta
  • Transplantation Conditioning*
  • Whole-Body Irradiation

Substances

  • Antigens, CD34
  • Fetal Hemoglobin
  • Busulfan